1. Home
  2. ANVS vs LODE Comparison

ANVS vs LODE Comparison

Compare ANVS & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • LODE
  • Stock Information
  • Founded
  • ANVS 2008
  • LODE 2008
  • Country
  • ANVS United States
  • LODE United States
  • Employees
  • ANVS N/A
  • LODE N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • LODE Major Chemicals
  • Sector
  • ANVS Health Care
  • LODE Industrials
  • Exchange
  • ANVS Nasdaq
  • LODE Nasdaq
  • Market Cap
  • ANVS 92.6M
  • LODE 79.6M
  • IPO Year
  • ANVS 2020
  • LODE N/A
  • Fundamental
  • Price
  • ANVS $5.01
  • LODE $0.30
  • Analyst Decision
  • ANVS Strong Buy
  • LODE Buy
  • Analyst Count
  • ANVS 6
  • LODE 1
  • Target Price
  • ANVS $29.67
  • LODE $2.60
  • AVG Volume (30 Days)
  • ANVS 488.6K
  • LODE 16.7M
  • Earning Date
  • ANVS 11-08-2024
  • LODE 02-26-2025
  • Dividend Yield
  • ANVS N/A
  • LODE N/A
  • EPS Growth
  • ANVS N/A
  • LODE N/A
  • EPS
  • ANVS N/A
  • LODE N/A
  • Revenue
  • ANVS N/A
  • LODE $1,864,811.00
  • Revenue This Year
  • ANVS N/A
  • LODE $69.41
  • Revenue Next Year
  • ANVS N/A
  • LODE $56.83
  • P/E Ratio
  • ANVS N/A
  • LODE N/A
  • Revenue Growth
  • ANVS N/A
  • LODE 117.46
  • 52 Week Low
  • ANVS $4.21
  • LODE $0.13
  • 52 Week High
  • ANVS $20.00
  • LODE $1.01
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 44.02
  • LODE 39.65
  • Support Level
  • ANVS $4.61
  • LODE $0.26
  • Resistance Level
  • ANVS $4.95
  • LODE $0.54
  • Average True Range (ATR)
  • ANVS 0.38
  • LODE 0.12
  • MACD
  • ANVS 0.07
  • LODE -0.04
  • Stochastic Oscillator
  • ANVS 40.40
  • LODE 6.49

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About LODE Comstock Inc.

Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries. The segments of the company are Fuels Metals, Mining, Strategic Investments, and Corporate. The company derives maximum revenue from Strategic Investments segment. The Strategic Investments Segment includes minority equity investments in Quantum Generative Materials LLC (physics-based artificial intelligence), Green Li-ion Pte Limited (lithium-ion battery recycling and cathode production), Sierra Springs Opportunity Fund (strategic direct investment in northern Nevada real estate), and other equity or equity-linked investments.

Share on Social Networks: